XOMA to Announce Fourth Quarter and Full Year 2016 Financial Results and Host Conference Call Focused on its New Strategic Di...
March 14 2017 - 7:00AM
XOMA Corporation (Nasdaq:XOMA), a pioneer in the discovery and
development of therapeutic antibodies, announced today it will
issue its fourth quarter and full year 2016 financial results
before the market opens on Thursday, March 16, 2017. In
conjunction, the Company will host a conference call at 9:00 a.m.
ET on Thursday, March 16, 2017, to review its business highlights
and describe XOMA’s new strategic direction and initiatives.
The webcast can be accessed via the Investors and Media section
of XOMA's website at http://investors.xoma.com/events.cfm and
will be available for replay. An accompanying slide presentation
also can be accessed via the XOMA website. Telephone numbers for
the live conference call are 1-877-369-6589 (U.S./Canada) and
1-408-337-0122 (international) with the passcode 82058103.
About XOMA CorporationXOMA has an extensive
portfolio of products, programs, and technologies that are the
subject of licenses the Company has in place with other biotech and
pharmaceutical companies. Many of these licenses are the
result of the Company’s pioneering efforts in the discovery and
development of antibody therapeutics. There are more than 20
such programs that are fully funded by partners and could produce
milestone payments and royalty payments in the future. In
order to maximize its value in a licensing transaction, XOMA
continues to invest in X358, an allosteric monoclonal antibody that
reduces insulin receptor activity, as the antibody could have a
major impact on the treatment of hyperinsulinism. For more
information, visit www.xoma.com.
CONTACTS:
Investor contact:
Luke Heagle
Pure Communications
+1 910-726-1372
lheagle@purecommunications.com
Media contact:
Colin Sanford
Pure Communications
+1 415-946-1094
csanford@purecommunications.com
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Mar 2024 to Apr 2024
XOMA (NASDAQ:XOMA)
Historical Stock Chart
From Apr 2023 to Apr 2024